BioPharmSignal logoBioPharmSignal

Biotech News

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical (VANI)Vivani MedicalEarnings

VANI (VANI) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is vani.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

VANIVivani Medical2026-05-13 20:05 EST

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

VANIVivani Medical2025-11-13 12:45 EST

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

MISTMilestone Pharmaceuticals Inc.2026-03-20 11:55 EST

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT

MISTMilestone Pharmaceuticals Inc.2026-03-12 12:00 EST

Milestone Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 20, 2026

MLYSMineralys Therapeutics2026-03-09 12:00 EST

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026

ALGSAligos Therapeutics2026-03-05 13:00 EST

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

MNKDMannKind2026-02-26 13:00 EST

MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

MNKDMannKind2026-02-18 14:00 EST

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

CVRXCVRx2026-02-12 21:05 EST

CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

EMBCEmbecta2025-11-25 11:30 EST

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

View all latest news

Vivani Medical

Vivani Medical is a drug-delivery company focused on long-acting implantable therapies and diabetes-related applications. Its platform is built around improving how medicines are delivered over time.

Recent company news

VANIVivani Medical2026-07-14 20:03 EST

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

VANIVivani Medical2026-07-07 11:35 EST

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

VANIVivani Medical2026-07-02 12:00 EST

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

VANIVivani Medical2026-06-26 11:30 EST

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

VANIVivani Medical2026-06-25 11:30 EST

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Stock data

Close
1.30 USD
Market cap
112.11M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States